Mineralys Therapeutics

MLYSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.256 B

$27.35 +1.33%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$154.7M

Loss-making

Shares outstanding

82,399,478

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#101UroGen PharmaURGN$2.30B
#102Palvella TherapeuticsPVLA$2.27B
#103Mineralys TherapeuticsMLYS$2.26B
#104Harmony BiosciencesHRMY$2.24B
#105SELLAS Life Sciences GroupSLS$2.23B

Where these numbers come from

Share counts and financials for Mineralys Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.